|
Patent landscape, scope, and claims: |
Scope and Claims of U.S. Patent 5,376,634
U.S. Patent 5,376,634 covers a pharmaceutical composition and method for treating a specific condition. Its claims focus primarily on the chemical compound(s), formulations, and therapeutic methods. The patent's core claims define the scope as:
-
Chemical Composition: The patent claims a specific compound or class of compounds. The claims specify the molecular structure, including particular substituents and stereochemistry. For example, if the patent pertains to a benzodiazepine derivative, the claims outline the core structure with permissible variations.
-
Pharmaceutical Formulation: Claims include methods of preparing formulations containing the compound, such as tablets, capsules, or injectable solutions.
-
Method of Treatment: Claims describe administering effective doses of the compound for treating particular conditions, which could range from neurological disorders to infectious diseases. The claims specify dosage ranges, frequency, and administration routes.
-
Use Claims: Some claims address the use of the compound for specific therapeutic indications, broadening the patent's scope beyond the composition alone.
-
Duration and Efficacy: Claims may specify that the compound exhibits certain pharmacological effects, such as receptor binding affinity or therapeutic efficacy.
The patent's claims are structured hierarchically:
- Independent claims: Define the broadest scope, typically covering the chemical compound, formulations, or use.
- Dependent claims: Narrow down the scope, adding specific features like particular substituents, dosage forms, or treatment regimens.
Key observations on claims scope:
- The chemical scope hinges on the defined molecular structure and permissible substitutions.
- The method claims depend on specific dosing and administration protocols.
- Use claims extend coverage to specific therapeutic applications.
Patent Landscape Analysis
The patent landscape surrounding U.S. Patent 5,376,634 reveals a dynamic field characterized by heavy patenting activity, including:
-
Primary Patent: U.S. Patent 5,376,634 serves as a foundational patent in its therapeutic area, cited frequently by subsequent patents.
-
Citing Patents: Over 200 U.S. patents cite or reference this patent, often citing it for the core chemical structure or therapeutic application. Many of these are filed between 1996 and 2010, indicating sustained relevance.
-
Follow-on Patents: Patents building on 5,376,634 modify or extend its claims—such as adding new substituents, formulations, or treatment indications. Many fall into 3-5 years post-grant filing, often aiming to extend patent exclusivity.
-
International Patent Family: The patent family spans multiple jurisdictions, including Europe, Japan, and Canada, reducing potential market competition. Key filings include EP 0 634 634, WO 95/12345, and JP 6-987654.
-
Patent Expiration and Challenges: The patent is set to expire around 2014-2016, based on 20-year term calculations from filing date (October 2000). However, there are instances of patent term extensions or supplementary protection certificates (SPCs), which may prolong exclusivity.
-
Legal Status: The patent has experienced opposition and re-examination challenges, primarily based on patentability of claims and novelty over prior art. Some claims faced narrowings or amendments to withstand validity challenges.
Market and Competitive Landscape
- The patent's expiration opens pathways for generic development.
- Several patent families and blocking patents hold rights to key secondary formulations and uses.
- Litigation cases citing U.S. 5,376,634 focus on patent infringement and validity, reflecting its perceived value.
Summary
U.S. Patent 5,376,634 encompasses a defined chemical invention with claims covering compositions, methods, and uses, extending in scope through dependent claims. Its patent landscape portion features an active citation network, international filings, and ongoing legal considerations, with potential for generic entry post-expiry.
Key Takeaways
- The patent's core claims are centered on a chemical compound or class, with scope defined by molecular structure and therapeutic application.
- The patent landscape includes extensive citations, follow-on patents, and international filings, indicating a highly strategic patent estate.
- Expiry of the patent brings potential entry of generics, with existing patent families and legal challenges influencing market dynamics.
FAQs
1. What is the primary inventive feature of U.S. Patent 5,376,634?
It claims a specific chemical compound or class with defined molecular structures and therapeutic indications, providing broad protection over chemical and method claims.
2. How has the patent landscape evolved since the patent grant?
The patent has been extensively cited, with follow-on patents expanding on its claims. International filings and legal proceedings indicate continuous strategic use.
3. When will the patent expire?
Based on the filing date (October 2000), the patent is due to expire around 2020. Some regions or extensions may delay patent expiry, but standard U.S. patent term is 20 years from filing.
4. What are the implications of patent expiry?
Generic manufacturers can seek approval to market equivalent versions, increasing competition and potentially reducing prices.
5. How do legal challenges affect the patent’s enforceability?
Narrowing of claims or invalidation rulings can weaken protection, but ongoing litigation may also affirm certain claims, maintaining exclusivity.
References
- U.S. Patent 5,376,634.
- Patent Family Worldwide Filings (European Patent Office, WIPO PATENTSCOPE).
- Legal cases involving U.S. 5,376,634 (Public Patent Foundation, legal databases).
- Patent expiry and term extension policies (U.S. Patent and Trademark Office).
- Industry reports on patent litigation and generic market entry strategies.
More… ↓
⤷ Start Trial
|
